 |
市場調查報告書
商品編碼
1198730
椎骨壓縮性骨折器械市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)Vertebral Compression Fracture Devices Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內 (2022-2027)，椎骨壓縮性骨折器械市場預計將以 8.3% 的複合年增長率增長。
COVID-19 對脊椎壓縮性骨折裝置的流行產生了重大影響，因為重點是抗擊 COVID-19 感染和減少脊柱手術。 例如，根據《世界神經外科雜誌》上發表的題為“COVID-19 大流行對中歐脊柱手術的影響”的研究，“COVID-19 感染對中歐脊柱手術的影響。一項基於問卷調查的研究” 2021 年 9 月，在中歐，COVID-19 大流行限制了脊柱外科病房的監管。 擇期手術減少，可以將更多資源分配給嚴重急性呼吸道冠狀病毒感染患者。
推動這一市場發展的主要因素包括骨質疏鬆症和關節炎負擔的增加、外傷和癌症負擔的增加、脊柱手術的進步以及微創手術意識的提高。
根據發表在《骨科外科與研究雜誌》上的一項題為“全球骨質疏鬆症患病率：2021 年 10 月的全面系統回顧和薈萃分析”的研究，骨質疏鬆症的全球患病率為 18.3%。 女性骨質疏鬆症的全球患病率為 23.1%，而男性骨質疏鬆症的全球患病率為 11.7%。 他們還發現，18 歲至 95 歲的人群患骨質疏鬆症的頻率最高。 骨關節炎患者日常簡單運動就容易發生椎體壓縮性骨折，骨關節炎的負擔在世界範圍內都很高，期待有用。
此外，由於這些設備的採用率不斷提高，預計主要市場參與者通過推出自己的產品而採取的更多舉措將進一步推動研究市場的增長。 例如，2020 年 9 月，ZI Medical Products, LLC 的 Kiva 椎體壓縮性骨折（VCF）治療系統在歐洲獲得 CE 標誌認證。 這是一種使用單隔室 PEEK 植入物的 VCF 治療方法，已在美國取得臨床和商業上的成功。
此外，2020 年 8 月，IZI Medical Products 推出了 Osteosite Vertebral Balloon，這是一種用於椎體增強手術的球囊。 Osteosite Balloon 完善了 IZI 提供的椎體壓縮性骨折 (VCF) 治療方案，包括骨細胞椎體成形術和骨細胞球囊延長術、Blazer 曲線針延長術和 Kiva PEEK 植入物延長術。骨細胞球囊是 IZI 提供的椎體壓縮性骨折的最佳治療選擇。 這些在市場上推出新產品的努力將進一步推動市場的增長。
除上述因素外，對於 55 歲以下沒有或僅有輕微創傷的個體，應評估轉移性癌症作為椎骨壓縮性骨折原因的可能性。 已知許多惡性腫瘤會通過脊柱骨轉移。 然後，癌症可能會破壞部分椎骨，削弱它們直至塌陷。 例如，2020年12月，國際癌症研究機構（IARC）發布的最新報告《Globocan 2020》指出，2020年全球將有1930萬癌症患者和1000萬癌症死亡人數。到
但是，與術後並發症（例如出血、椎骨後部骨折）、設備的嚴格監管批准以及報銷問題相關的風險預計會阻礙市場增長。
椎體壓縮骨折器械市場趨勢
預計在預測期內，微創脊柱外科領域將佔很大份額
微創脊柱手術領域預計將佔據重要的市場份額，並且很可能在預測期內佔據這一份額。
灌注技術的創新、脊柱融合術的改進以及專業手術器械和機器人技術的發展提供了將椎體壓縮性骨折手術推進到微創方法所需的工具。 微創脊柱 (MIS) 手術的目標是穩定椎骨和脊柱關節並減輕脊神經的壓力。 它通常由椎體壓縮性骨折、椎體不穩定、骨刺、椎間盤突出、脊柱側凸和脊柱腫瘤等情況引起。
預計椎體壓縮骨折器械市場中市場參與者的積極性將進一步推動該細分市場的增長。 例如，2021 年 2 月，DePuy Synthes 與 Expanding Innovations 簽署了一項協議，在美國銷售 X-Pac 可擴展腰椎籠式系統。 X-Pac Cage 是 DePuy Synthes 現有產品線的補充，可在退行性腰椎和微創脊柱節段中實現更徹底的手術。
此外，2021 年 10 月，美敦力 (Medtronic) 將在其微創脊柱技術生態系統中引入三款新設備，這是一家為外科醫生和患者融合脊柱植入物、生物製劑、導航、機器人技術和人工智能數據的公司。 因此，預計脊柱手術設備主要參與者的此類舉措將在預測期內推動該細分市場的增長。
因此，由於上述因素，預計該細分市場將在預測期內獲得牽引力。
北美佔據主要市場份額，預計在預測期內保持不變
北美在椎體壓縮骨折裝置市場中佔據主要份額，預計在預測期內也將如此。
該地區的市場增長因素包括微創手術的進步、目標疾病患病率的上升、創傷相關頭部和脊柱損傷研究經費的增加，以及主要市場參與者的穩固立足點。
根據美國疾病控制與預防中心發布的《骨關節炎國家公共衛生議程：2020年更新》報告，骨關節炎（OA）是最常見的關節炎形式，是一種嚴重的慢性疾病，影響7人中有1人，影響3250萬人。 骨質疏鬆症等高發病率預計將推動該地區研究市場的增長，因為椎體壓縮骨折裝置被廣泛用於治療與骨質疏鬆症相關的骨折。
此外，主要市場參與者的主動性不斷提高預計也將在預測期內推動該地區的市場增長。 例如，2021 年 8 月，Vertefix HV Cement 是一種獨特的解決方案，可滿足椎體成形術和枕骨成形術中水泥注射過程中實時流動可視化的需求，可用於治療椎體壓縮性骨折。它由 IZI Medical Products LLC 銷售，治療介入放射學設備和產品的製造商。 這些努力有望促進水泥的採用和椎體壓縮性骨折治療裝置的引入，促進美國市場的增長。
此外，根據《2021 年美國健康排名高級報告》，美國 65 歲及以上的人口超過 5400 萬。 美國老年人口數量急劇膨脹，到2050年，美國65歲及以上人口總數預計將達到8570萬，佔總人口的近20%。 由於椎骨壓縮性骨折在老年人中更常見，預計老年人口的增加將推動該地區的市場增長。
在此背景下，預計該地區的市場在預測期內將會增長。
椎體壓縮骨折器械市場競爭者分析
椎體壓縮骨折器械市場競爭激烈。 市場預計將受到主要市場參與者增加產品發布以及市場參與者之間合作夥伴關係、併購的增加的推動。 市場上的主要參與者包括 Spirit Spine Holding Corporation Inc、IZI Medical Products、Stryker Corporation (Orthovita, Inc.)、Orthofix Interventional N.V.、Johnson and Johnson (DePuy Synthes)、Globus Medical, Inc 和 Merit Medical Systems Inc。它包括公司如
其他好處
- Excel 格式的市場預測 (ME) 表
- 三個月的分析師支持
內容
第1章介紹
- 研究假設和市場定義
- 調查範圍
第2章研究方法論
第 3 章執行摘要
第4章市場動態
- 市場概覽
- 市場驅動力
- 增加關節炎和骨質疏鬆症的負擔
- 由於外傷、癌症或其他原因導致脊柱受壓而增加負擔
- 提高對脊柱手術進展的認識
- 市場製約因素
- 與出血和椎骨後部骨折等術後並發症相關的風險
- 嚴格的監管審批程序和報銷問題
- 波特的五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第 5 章市場細分（市場規模：百萬美元）
- 按產品類型
- Balloon Cubo Platy
- 椎板成形術
- 通過手術
- 開放式脊柱手術
- 微創脊柱手術
- 最終用戶
- 醫院
- 門診手術中心
- 其他（外傷中心、其他）
- 按地區
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
- 其他歐洲地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東
- 海灣合作委員會
- 南非
- 其他中東地區
- 南美洲
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第6章競爭格局
- 公司簡介
- Spirit Spine Holding Corporation Inc
- Medtronic Inc.
- IZI Medical Products
- Stryker Corporation（Orthovita, Inc.）
- Spine Wave, Inc.
- Orthofix Interventional N.V.
- Zimmer Biomet
- Johnson and Johnson（DePuy Synthes）
- Zavation
- Globus Medical, Inc.
- Merit Medical Systems Inc.
第7章 市場機會與今後動向
The Vertebral Compression Fracture Devices Market is expected to register a CAGR of 8.3 % during the forecast period (2022-2027).
COVID-19 has significantly impacted the vertebral compression fracture devices during the pandemic due to the shift of focus towards the battling of COVID-19 infection and the decrease in spine surgeries. For instance, according to the study published in World Neurosurgery, titled 'The Impact of the COVID-19 Pandemic on Spine Surgery in Central Europe: A Questionnaire-Based Study' in September 2021, in Central Europe, the COVID-19 pandemic resulted in limiting regulations for spinal surgery units. Elective surgical operations were decreased, allowing more resources to be allocated to patients with severe acute respiratory coronavirus infections.
The major factors driving this market include the growing burden of osteoporosis and arthritis, the rising burden of trauma and cancers, increase in awareness about the advancements in spinal surgeries and minimally invasive surgeries, among others.
According to the study published in the Journal of Orthopaedic Surgery and Research, titled 'The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis in October 2021, the global prevalence of osteoporosis was estimated to be 18.3 %. The global prevalence of osteoporosis in women was found to be 23.1 percent, whereas the global prevalence of osteoporosis in males was found to be 11.7 percent. People between the ages of 18 and 95 were found to have the highest frequency of osteoporosis. As osteoarthritic patients are prone to vertebral compression fractures by simple daily activities, the market is expected to drive due to the huge burden of osteoarthritis globally due to the rise in the adoption of vertebral compression fracture devices.
In addition, a rising initiative from the key market players by the launch of their products is further expected to drive the growth of the market studied due to the rise in the adoption of these devices. For instance, in September 2020, The ZI Medical Products, LLC's Kiva Vertebral Compression Fracture (VCF) Treatment System received CE Mark certification in Europe for the Kiva system. It is a VCF treatment method based on a unipedicular PEEK implant that has experienced clinical and commercial success in the United States.
Furthermore, in August 2020, IZI Medical Products launched its Osteo-Site Vertebral Balloon for vertebral augmentation. The Osteo-Site Balloon completes IZI's offering of Vertebral Compression Fracture ("VCF") treatment options, which include osteo-Site vertebroplasty, and osteo-site balloon kyphoplasty, blazer curved needle augmentation, and kiva PEEK Implant-based augmentation. Such initiatives of launching novel products in the market will further propel market growth.
Besides the above-mentioned factors, in individuals under the age of 55 who have had no or only minor trauma, metastatic cancers should be evaluated as a possible cause for vertebral compression fractures. Many forms of malignancies are known to spread via the spine's bones. During this, parts of the vertebra may be destroyed by cancer, weakening the bone until it Collapses. For instance, in December 2020, the International Agency for Research on Cancer (IARC) issued an updated Globocan 2020 report, revealing that the worldwide cancer burden has increased to 19.3 million cases and 10 million cancer deaths in 2020.
However, risks associated with post-surgical complications, including hemorrhage, vertebral posterior element fracture, and others, stringent regulatory approval for the devices, and reimbursement issues, among others, are expected to hamper the market growth.
Vertebral Compression Fracture Devices Market Trends
Minimally Invasive Spine Surgery Segment is Expected to Hold a Significant Share Over the Forecast period.
The minimally invasive spine surgery segment is expected to hold a significant market share, and it is expected to do the same over the forecast period.
With innovations in perfusion techniques, refinement of spinal fusion, and the development of specialized surgical instruments and robotic technology, vertebral compression fracture surgery was provided with the necessary tools to progress to less invasive approaches. The goal of the minimally invasive spine (MIS) surgery is to stabilize the vertebral bones and spinal joints and/or relieve the pressure being applied to the spinal nerves, often a result of conditions such as vertebral compression fractures, spinal instability, bone spurs, herniated discs, scoliosis, or spinal tumors.
The rise in initiatives by the market players in the vertebral compression fracture devices market is expected to drive this segment growth further. For instance, in February 2021, DePuy Synthes formed a deal with Expanding Innovations Inc. to market the X-Pac Expandable Lumbar Cage System in the United States. The X-Pac Cage adds to DePuy Synthes' existing product line, allowing for a more thorough procedure in the lumbar degenerative and minimally invasive spine segments.
In addition, in October 2021, Medtronic introduced three new devices to its minimally invasive spinal technologies ecosystem, making it the company to combine spinal implants, biologics, navigation, robotics, and AI-powered data for surgeons and patients. Such initiatives by the key players in spine surgical devices are therefore expected to drive the growth of this segment over the forecast period.
Therefore, owing to the aforementioned factors, this segment is expected to drive over the forecast period.
North America Holds a Major Share and Expected to do Same in the Forecast Period
North America holds a major share in the vertebral compression fracture devices market, and it is expected to do the same over the forecast period.
The factors owing to the growth of the market in this region include advancements in minimally invasive surgeries, the rise in prevalence of target diseases, the rise in research funding for trauma-related head and spine injuries, strong foothold of key market players, among others.
According to the report, 'A National Public Health Agenda for Osteoarthritis: 2020 Update' published by the Center for Disease Control and Prevention, Osteoarthritis (OA) is the most common form of arthritis, and it is a serious chronic disease that affects 1 in 7 United States adults making the count to 32.5 million people. Such a high incidence of osteoporosis is expected to drive the growth of the market studied in this region due to the higher adoption of vertebral compression fracture devices in fractures related to osteoporosis.
In addition, rising initiatives of key market players are also expected to propel the market growth in this region over the forecast period. For instance, in August 2021, Vertefix HV Cement, a unique solution that addresses the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures, was launched by IZI Medical Products LLC, a manufacturer of interventional radiology devices and products to treat vertebral compression fractures. Such initiatives will lead to increased adoption of vertebral compression fracture devices along with the adoption of cement, driving the market growth in the United States.
Furthermore, according to the America Health Rankings 2021 Senior Report, in the United States, there are more than 54 million individuals aged 65 and above. The number of older adults in the United States is huge and expanding, and by 2050, the total number of persons 65 and over in the United States is expected to reach 85.7 million, or nearly 20% of the total population. As vertebral compression fractures are more common as people become older, the rise in the elderly population will therefore be expected to propel the market growth in this region.
Therefore, owing to the above-mentioned factors, the market is expected to drive in this region over the forecast period.
Vertebral Compression Fracture Devices Market Competitor Analysis
The vertebral compression fracture devices market is moderately competitive. The market is expected to drive due to the rise in product launches by the key market players, the rise in partnerships, mergers, and acquisitions among the market players, among others. Some of the key players in the market include Spirit Spine Holding Corporation Inc, IZI Medical Products, Stryker Corporation (Orthovita, Inc.), Orthofix Interventional N.V., Johnson and Johnson (DePuy Synthes), Globus Medical, Inc., and Merit Medical Systems Inc., among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Burden of Arthritis and Osteoporosis
- 4.2.2 Rising Burden of Compressed Bones of the Spine due to Trauma, Cancer, and Others
- 4.2.3 Increase in Awareness About Advancements in Spinal Surgeries
- 4.3 Market Restraints
- 4.3.1 Risks Associated with Post-Surgical Complications Including Hemorrhage, Vertebral Posterior Element Fracture and Others
- 4.3.2 Stringent Regulatory Approval Procedures and Reimbursement Issues
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market size in USD million)
- 5.1 By Product Type
- 5.1.1 Balloon kyphoplasty
- 5.1.2 Vertebroplasty
- 5.2 By Surgery
- 5.2.1 Open spine surgery
- 5.2.2 Minimally Invasive Spine Surgery
- 5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Ambulatory Surgical Centers
- 5.3.3 Others (Trauma Centers and Others)
- 5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
- 5.4.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Spirit Spine Holding Corporation Inc
- 6.1.2 Medtronic Inc.
- 6.1.3 IZI Medical Products
- 6.1.4 Stryker Corporation (Orthovita, Inc.)
- 6.1.5 Spine Wave, Inc.
- 6.1.6 Orthofix Interventional N.V.
- 6.1.7 Zimmer Biomet
- 6.1.8 Johnson and Johnson (DePuy Synthes)
- 6.1.9 Zavation
- 6.1.10 Globus Medical, Inc.
- 6.1.11 Merit Medical Systems Inc.
